An early combination of concurrent chemoradiotherapy with immune checkpoint inhibitors for cervical cancer is superior to a late combination: a propensity-score matching analysis

An early combination of concurrent chemoradiotherapy with immune checkpoint inhibitors for cervical cancer is superior to a late combination: a propensity-score matching analysis

PurposeThis study compared the timing effects of immune checkpoint inhibitor (ICIs) administration on the efficacy and safety of concurrent chemoradiotherapy for cervical cancer.MethodsThis study included patients with advanced cervical cancer who received concurrent chemoradiotherapy with ICIs. The...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi-Ming Ma, Shu-Xia Cheng, Ming-Chuan Zhang, Hui-Ying Zhang, Jun-Jiao Gu, Pan-Pan Zhao, Hong Ge
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Oncology
Subjects:
immune checkpoint inhibitors
cervical cancer
application timing
progression-free survival
objective response rate
treatment-related adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1429176/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1429176/full

Similar Items